Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children
- PMID: 1861208
- DOI: 10.1016/s0022-3476(05)80733-4
Mass screening in Japan increased the detection of infants with neuroblastoma without a decrease in cases in older children
Abstract
Analysis of data from the Kanto-Ko-Shin-Etsu Branch of the Japan Children's Cancer Registry revealed that mass screening for neuroblastoma increased the detection of cases in infants younger than 1 year from about 25% before screening to about 50%, and the percentage of neuroblastomas among all pediatric cancers almost doubled, from approximately 10% to 19.3%. However, when the cases found on screening were subtracted, the numbers after the onset of mass screening were similar to those before screening. It is likely that neuroblastoma mass screening has identified a unique type of tumor, which may not be recognized without mass screening, rather than that it has contributed to the earlier diagnosis of tumors in older children.
Similar articles
-
Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma Screening.Lancet. 1991 Feb 9;337(8737):344-6. doi: 10.1016/0140-6736(91)90957-q. Lancet. 1991. PMID: 1671243 Review. No abstract available.
-
Mass screening and age-specific incidence of neuroblastoma in Saitama Prefecture, Japan.J Clin Oncol. 1995 Aug;13(8):2033-8. doi: 10.1200/JCO.1995.13.8.2033. J Clin Oncol. 1995. PMID: 7636545
-
Mass screening for neuroblastoma in Japan.Pediatr Hematol Oncol. 1991 Apr-Jun;8(2):93-109. doi: 10.3109/08880019109033437. Pediatr Hematol Oncol. 1991. PMID: 1863547 Review.
-
Results of mass screening for neuroblastoma in Sapporo, Japan.Prog Clin Biol Res. 1991;366:595-601. Prog Clin Biol Res. 1991. PMID: 2068178 No abstract available.
-
Different genomic and metabolic patterns between mass screening-positive and mass screening-negative later-presenting neuroblastomas.Cancer. 1991 Nov 1;68(9):2037-44. doi: 10.1002/1097-0142(19911101)68:9<2037::aid-cncr2820680932>3.0.co;2-c. Cancer. 1991. PMID: 1913552
Cited by
-
Neuroblastoma detected by mass screening: the Tumor Board's role in its treatment.Pediatr Surg Int. 2004 Jan;20(1):27-32. doi: 10.1007/s00383-003-1070-x. Epub 2003 Dec 19. Pediatr Surg Int. 2004. PMID: 14689211
-
Neonatal neuroblastoma.Arch Dis Child Fetal Neonatal Ed. 1999 Sep;81(2):F134-7. doi: 10.1136/fn.81.2.f134. Arch Dis Child Fetal Neonatal Ed. 1999. PMID: 10448183 Free PMC article.
-
Alkaptonuria detected by neuroblastoma screening system.Eur J Pediatr. 1992 May;151(5):388-9. doi: 10.1007/BF02113266. Eur J Pediatr. 1992. PMID: 1396899 No abstract available.
-
Neuroblastoma.Indian J Pediatr. 1998 Sep-Oct;65(5):691-705. doi: 10.1007/BF02731044. Indian J Pediatr. 1998. PMID: 10773924 Review.
-
Is neuroblastoma screening evaluation needed and feasible?Br J Cancer. 1995 Jun;71(6):1125-31. doi: 10.1038/bjc.1995.219. Br J Cancer. 1995. PMID: 7779698 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials